LABD

Equity ETFs

is-it-finally-time-to-buy-biotech-etfs

As Election Day Arrives, Is It Finally Time to Buy Biotech ETFs?

By Tom LydonNovember 8, 2016

Equity ETFs

taking-the-technical-temperature-of-biotech-etfs

Taking the Technical Temperature of Biotech ETFs

By Tom LydonOctober 21, 2016

Featured

15 Most Read ETF Articles of the Week (August 22-26)

10 Most Read ETF Articles of the Week (August 22-26)

By Brenton GarenAugust 26, 2016

Equity ETFs

Clinton's Attack on Mylan Reminds Biotech ETF Investors of Election Risks

Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks

By Max ChenAugust 25, 2016

Alternative ETFs

Hot Spots That Short-Term ETF Traders Are Targeting

Hot Spots Short-Term ETF Traders Are Targeting

By Max ChenJuly 19, 2016

Equity ETFs

Finally A Biotech ETF Bounce?

By Brenton GarenJune 1, 2016

Equity ETFs

Resisting the Temptation of Biotech ETFs

Resisting the Temptation of Biotech ETFs

By Brenton GarenMay 16, 2016

Equity ETFs

Hit The Lab With These 17 Biotech ETFs

Hit The Lab With These 17 Biotech ETFs

By Tom LydonMay 2, 2016

Uncategorized

Biotech ETFs Among the Worst Hit Areas

By Tom LydonJanuary 28, 2016

Equity ETFs

Biotech ETFs Look Green on Earnings Concerns

By Tom LydonJanuary 11, 2016

Featured

Two Big Factors Hurting Biotech ETFs

By Tom LydonOctober 6, 2015

Featured

Biotech Blues Could Continue

By Tom LydonOctober 2, 2015

Featured

Where Do Biotech ETFs Go From Here?

By Tom LydonSeptember 29, 2015

Featured

Clinton Delivers Poison Pill To Biotech ETFs

By Tom LydonSeptember 21, 2015

Featured

How to Get Bearish on Biotech With ETFs

By Tom LydonJuly 28, 2015

Featured

Impressive Bull Run in Biotech ETFs Causes Some to Take Pause

By Tom LydonJuly 16, 2015

Featured

Mess With the Leveraged Biotech Bull ETF and get the Horns

By Todd ShriberJune 23, 2015

Featured

Volatility in Healthcare ETFs Ahead of Supreme Court’s Obamacare Ruling

By Tom LydonJune 15, 2015

Previous 1 2 3 4 5 Next